每年專案
指紋
查看啟用 癌症生物學與藥物研發研究所 的研究主題。這些主題標籤來自此機構會員的作品。共同形成了獨特的指紋。
網路
國家/地區層面的近期外部共同作業。按一下圓點深入探索詳細資料，或
概要
-
許 凱程
- 癌症生物學與藥物研發研究所 - 教授
- 癌症生物學與藥物研發博士學位學程 - 合聘教授
- 新藥研發產業博士學位學程 - 合聘教授
- 國際轉譯科學博士學位學程 - 合聘教授
- 臨床基因體學暨蛋白質體學碩士學位學程 - 合聘教授
- 臺北醫學大學新藥開發研究中心 - 成員
- 臺北醫學大學癌症轉譯研究中心 - 成員
人員: Researcher
-
(Thyroid) Hormonal regulation of breast cancer cells
Hercbergs, A., Lin, H. Y., Mousa, S. A. & Davis, P. J., 1月 2023, 於: Frontiers in Endocrinology. 13, 1109555.研究成果: 雜誌貢獻 › 簡短的問卷調查 › 同行評審
開啟存取 -
A low-molecular-weight chitosan fluorometric-based assay for evaluating antiangiogenic drugs
Wang, C. Y., Chou, C. M., Chu, C. Y., Chen, A., Liu, E. H., Liu, C. Y., Lee, Y. L. A., Mi, F. L. & Cheng, C. H., 1月 2023, 於: International Journal of Biological Macromolecules. 224, p. 927-937 11 p.研究成果: 雜誌貢獻 › 文章 › 同行評審
-
ASPM activates Hedgehog and Wnt signaling to promote small cell lung cancer stemness and progression
Cheng, L-H., Hsu, C-C., Tsai, H-W., Liao, W-Y., Yang, P-M., Liao, T-Y., Hsieh, H-Y., Chan, T-S. & Tsai, K. K., 1月 1 2023, 於: Cancer Research.研究成果: 雜誌貢獻 › 文章 › 同行評審
資料集
-
Additional file 1 of Investigating the potential effects of selective histone deacetylase 6 inhibitor ACY1215 on infarct size in rats with cardiac ischemia-reperfusion injury
Pan, S. (Contributor), Hsu, K. (Creator), Lin, T. E. (Creator), Lin, C. (Creator), Huang, H. (Contributor) & HuangFu, W. (Contributor), Figshare, 2020
DOI: 10.6084/m9.figshare.11992497.v1, https://doi.org/10.6084%2Fm9.figshare.11992497.v1
資料集: Dataset
-
Additional file 1 of EGFL6 promotes colorectal cancer cell growth and mobility and the anti‐cancer property of anti-EGFL6 antibody
Cheng, Y. (Creator), Cheng, C. (Creator), HuangFu, W. (Creator), Pan, S. (Creator), Sung, T. (Creator), Chang, F. (Creator), Huang, H. (Contributor), Huang, C. (Contributor), Wei, P. (Contributor) & Lee, Y. (Contributor), Figshare, 2021
DOI: 10.6084/m9.figshare.14228278.v1, https://doi.org/10.6084%2Fm9.figshare.14228278.v1
資料集: Dataset
-
Additional file 3: of Combination treatment strategy for pancreatic cancer involving the novel HDAC inhibitor MPT0E028 with a MEK inhibitor beyond K-Ras status
Chao, M. (Contributor), Chang, L. (Contributor), Tu, H. (Contributor), Chang, C. (Contributor), Lai, M. (Contributor), Chen, Y. (Creator), Liou, J. (Creator), Teng, C. (Contributor) & Pan, S. (Contributor), Figshare, 2019
DOI: 10.6084/m9.figshare.8202890.v1, https://springernature.figshare.com/articles/Additional_file_3_of_Combination_treatment_strategy_for_pancreatic_cancer_involving_the_novel_HDAC_inhibitor_MPT0E028_with_a_MEK_inhibitor_beyond_K-Ras_status/8202890/1
資料集: Dataset